Literature DB >> 1547020

Characterization and functional expression of genomic DNA encoding the human lymphocyte type n potassium channel.

Y C Cai1, P B Osborne, R A North, D C Dooley, J Douglass.   

Abstract

Voltage-gated potassium channels play important functional roles in the development and maintenance of human lymphocyte functions. One such channel, known as the type n channel, has been well defined in human T cells and exhibits unique functional properties that distinguish it from other species of potassium channels. We report the characterization of a human genomic DNA clone, HGK5, encoding a 523-amino-acid potassium channel protein encoded by an open reading frame on a single exon. RNA transcribed in vitro from HGK5 genomic DNA directs expression of functional voltage-dependent potassium currents in Xenopus oocytes. The functional characteristics of the expressed channels are strikingly similar to those of the type n channel on human T lymphocytes. This, together with the presence of significant levels of HGK5 mRNA in human T lymphocytes, supports the notion that HGK5 encodes the human type n voltage-gated potassium channel. The effects of concanavalin A treatment on HGK5 mRNA levels in cultured human T lymphocytes was also examined. Mitogenic concentrations of concanavalin A induced a time-dependent decrease in HGK5 mRNA levels, suggesting that previously observed increases in potassium current density following concanavalin A treatment of human T lymphocytes are not due to increased transcriptional activity of the type n potassium channel gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547020     DOI: 10.1089/dna.1992.11.163

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  15 in total

Review 1.  Molecular properties and physiological roles of ion channels in the immune system.

Authors:  M D Cahalan; H Wulff; K G Chandy
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

2.  State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.

Authors:  Malika Faouzi; John Starkus; Reinhold Penner
Journal:  Br J Pharmacol       Date:  2015-10-09       Impact factor: 8.739

3.  Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  Pflugers Arch       Date:  1992-02       Impact factor: 3.657

4.  The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel.

Authors:  H Rauer; S Grissmer
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels.

Authors:  J A Verheugen; H Korn
Journal:  J Physiol       Date:  1997-09-01       Impact factor: 5.182

6.  Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation.

Authors:  C Deutsch; L Q Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Differential effects of organotin compounds on voltage-gated potassium currents in lymphocytes and neuroblastoma cells.

Authors:  M Oortgiesen; E Visser; H P Vijverberg; W Seinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

8.  Elevation of intracellular Ca2+ in the physiologically relevant range does not inhibit voltage-gated K+ channels in human T lymphocytes.

Authors:  J A Verheugen
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

9.  Properties of voltage-gated potassium currents of microglia differentiated with granulocyte/macrophage colony-stimulating factor.

Authors:  C Eder; H G Fischer; U Hadding; U Heinemann
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

10.  Criteria for perforated-patch recordings: ion currents versus dye permeation in human T lymphocytes.

Authors:  I Chung; L C Schlichter
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.